Product Images Fluticasone Propionate Hfa

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Fluticasone Propionate Hfa NDC 50090-6055 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Fluticasone propionate chemical structure - fluticasonepropionatehfa spl graphic 01

Fluticasone propionate chemical structure - fluticasonepropionatehfa spl graphic 01

Figure 1. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Inadequately Controlled on Bronchodilators Alone: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 1) - fluticasonepropionatehfa spl graphic 02

Figure 1. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Inadequately Controlled on Bronchodilators Alone: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 1) - fluticasonepropionatehfa spl graphic 02

Figure 2. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 2) - fluticasonepropionatehfa spl graphic 03

Figure 2. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 2) - fluticasonepropionatehfa spl graphic 03

This appears to be a table of data related to the change in FEV (Forced Expiratory Volume) from a baseline, comparing the impact of various medications at different doses. The medications listed are Placebo and Fluticasone Propionate HFA (at doses of 83, 220, and 440 meg twice daily). The table includes 12 weeks of data, with the endpoint being the evaluation after that timeframe. This data can be used to analyze and compare the effectiveness of different doses of Fluticasone Propionate HFA as a treatment for respiratory conditions.*

Figure 3. A 16-Week Clinical Trial in Subjects Aged 12 Years and Older Requiring Chronic Oral Prednisone Therapy: Change in Maintenance Prednisone Dose - fluticasonepropionatehfa spl graphic 04

Figure 3. A 16-Week Clinical Trial in Subjects Aged 12 Years and Older Requiring Chronic Oral Prednisone Therapy: Change in Maintenance Prednisone Dose - fluticasonepropionatehfa spl graphic 04

The text provided appears to be a table showing the percentage of subjects with an increase in dose and reduction in dose for Fluticasone Propionate HFA at 440 and 880 meg twice daily. There is also a column for the placebo. However, there is not enough information provided to understand the full context of the table or its purpose.*

Figure A - fluticasonepropionatehfa spl graphic 05

Figure A - fluticasonepropionatehfa spl graphic 05

The product appears to be a metal canister with a dark orange plastic actuator and a mouthpiece. It also comes with a peach cap. More information is not available for the given text.*

Figure B - fluticasonepropionatehfa spl graphic 06

Figure B - fluticasonepropionatehfa spl graphic 06

Figure C - fluticasonepropionatehfa spl graphic 07

Figure C - fluticasonepropionatehfa spl graphic 07

Figure D - fluticasonepropionatehfa spl graphic 08

Figure D - fluticasonepropionatehfa spl graphic 08

Figure E - fluticasonepropionatehfa spl graphic 09

Figure E - fluticasonepropionatehfa spl graphic 09

The text appears to describe different attributes of a mouthpiece, such as its position and color, but it is not clear what object the mouthpiece belongs to or what context it is being used in. Therefore, the description is not specific or useful enough and it is not possible to provide a meaningful interpretation.*

Figure F - fluticasonepropionatehfa spl graphic 10

Figure F - fluticasonepropionatehfa spl graphic 10

This text is a simple direction to exhale or breathe out as much air as possible.*

Figure G - fluticasonepropionatehfa spl graphic 11

Figure G - fluticasonepropionatehfa spl graphic 11

Figure H - fluticasonepropionatehfa spl graphic 12

Figure H - fluticasonepropionatehfa spl graphic 12

Figure I - fluticasonepropionatehfa spl graphic 13

Figure I - fluticasonepropionatehfa spl graphic 13

Figure J - fluticasonepropionatehfa spl graphic 14

Figure J - fluticasonepropionatehfa spl graphic 14

Label Image - lbl500906055

Label Image - lbl500906055

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.